接种疫苗后 SARS-CoV-2 Delta 的传染性病毒脱落:一项纵向队列研究。

Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study.

机构信息

Department of Microbiology and Immunology, UCSF, California, United States of America.

Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.

出版信息

PLoS Pathog. 2022 Sep 12;18(9):e1010802. doi: 10.1371/journal.ppat.1010802. eCollection 2022 Sep.

Abstract

The impact of vaccination on SARS-CoV-2 infectiousness is not well understood. We compared longitudinal viral shedding dynamics in unvaccinated and fully vaccinated adults. SARS-CoV-2-infected adults were enrolled within 5 days of symptom onset and nasal specimens were self-collected daily for two weeks and intermittently for an additional two weeks. SARS-CoV-2 RNA load and infectious virus were analyzed relative to symptom onset stratified by vaccination status. We tested 1080 nasal specimens from 52 unvaccinated adults enrolled in the pre-Delta period and 32 fully vaccinated adults with predominantly Delta infections. While we observed no differences by vaccination status in maximum RNA levels, maximum infectious titers and the median duration of viral RNA shedding, the rate of decay from the maximum RNA load was faster among vaccinated; maximum infectious titers and maximum RNA levels were highly correlated. Furthermore, amongst participants with infectious virus, median duration of infectious virus detection was reduced from 7.5 days (IQR: 6.0-9.0) in unvaccinated participants to 6 days (IQR: 5.0-8.0) in those vaccinated (P = 0.02). Accordingly, the odds of shedding infectious virus from days 6 to 12 post-onset were lower among vaccinated participants than unvaccinated participants (OR 0.42 95% CI 0.19-0.89). These results indicate that vaccination had reduced the probability of shedding infectious virus after 5 days from symptom onset.

摘要

疫苗接种对 SARS-CoV-2 传染性的影响尚不清楚。我们比较了未接种和完全接种疫苗的成年人的纵向病毒脱落动力学。在症状出现后 5 天内招募 SARS-CoV-2 感染的成年人,并自我采集鼻拭子,每天采集两周,然后再间歇性采集两周。根据接种状态对症状发作进行分层,分析 SARS-CoV-2 RNA 载量和感染性病毒。我们检测了 1080 份来自 52 名未接种疫苗的成年人(在 Delta 之前的时期)和 32 名主要感染 Delta 的完全接种疫苗的成年人的鼻拭子。虽然我们在最大 RNA 水平、最大传染性滴度和病毒 RNA 脱落的中位数持续时间方面没有观察到接种状态的差异,但接种疫苗的人的 RNA 载量从最大值下降的速度更快;最大传染性滴度和最大 RNA 水平高度相关。此外,在具有传染性病毒的参与者中,未接种参与者的传染性病毒检测中位持续时间从 7.5 天(IQR:6.0-9.0)缩短至接种参与者的 6 天(IQR:5.0-8.0)(P=0.02)。因此,与未接种疫苗的参与者相比,接种疫苗的参与者在发病后 6 至 12 天内排出传染性病毒的几率较低(OR 0.42,95%CI 0.19-0.89)。这些结果表明,疫苗接种降低了从症状出现后 5 天开始排出传染性病毒的概率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b74/9499220/6addc74cf7cb/ppat.1010802.g001.jpg

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索